Loading…

Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1[beta] release through the inhibition of Nogo-A expression

Background Nogo-A is a member of the reticulon family of membrane-associated proteins and plays an important role in axonal remodeling. The present study aimed to investigate alterations in Nogo-A expression following traumatic brain injury (TBI)-induced inflammation and neuronal damage. Methods A w...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroinflammation 2012-06, Vol.9
Main Authors: Chao, Po-Kuan, Lu, Kwok-Tung, Jhu, Ji-Yi, Wo, Yu-Yuan Peter, Huang, Tai-Chun, Ro, Long-Sun, Yang, Yi-Ling
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Nogo-A is a member of the reticulon family of membrane-associated proteins and plays an important role in axonal remodeling. The present study aimed to investigate alterations in Nogo-A expression following traumatic brain injury (TBI)-induced inflammation and neuronal damage. Methods A weight-drop device was used to deliver a standard traumatic impact to rats. Western blot, RT-PCR and ELISA were used to analyze the expression of Nogo-A and IL-1[beta]. Nogo-A antisense, and an irrelevant control oligonucleotide was intracerebroventricularly infused. We also performed H & E staining and luxol fast blue staining to evaluate the neuronal damage and demyelination resulting from TBI and various treatments. Results Based on RT-PCR and western blot analyses, the expression of Nogo-A was found to be significantly upregulated in the hippocampus beginning eight hours after TBI. In addition, TBI caused an apparent elevation in IL-1[beta] levels and severe neuronal damage and demyelination in the tested animals. All of the TBI-associated molecular and cellular consequences could be effectively reversed by treating the animals with the anti-inflammatory drug indomethacin. More importantly, the TBI-associated stimulation in the levels of both Nogo-A and IL-1[beta] could be effectively inhibited by a specific Nogo-A antisense oligonucleotide. Conclusions Our findings suggest that the suppression of Nogo-A expression appears to be an early response conferred by indomethacin, which then leads to decreases in the levels of IL-1[beta] and TBI-induced neuron damage. Keywords: Nogo-A, Traumatic brain injury, Inflammation, IL-1[beta]
ISSN:1742-2094
1742-2094
DOI:10.1186/1742-2094-9-121